Literature DB >> 29892468

What is Heart Failure with Mid-range Ejection Fraction? A New Subgroup of Patients with Heart Failure.

Sunil K Nadar1, Osama Tariq1.   

Abstract

Since the publication of European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) in 2016, a new class of HF has been defined, namely HF with mildly reduced ejection fraction (HFmrEF). Although the name was new, there had long been awareness of the existence of a grey area between the two established classes of HF: HF with reduced ejection fraction and HF with preserved ejection fraction. Patients between these two classes were previously either excluded from HF studies or were included in the other groups. With the definition of this new group of patients, a door has opened for researchers to further explore their characteristics, treatment and outcomes. In this article we aim to clarify the existing literature on the clinical characteristics and pathophysiology of this newly-defined group of patients.

Entities:  

Keywords:  Acute and chronic heart failure; heart failure with mid-range ejection fraction; heart failure with preserved ejection fraction; heart failure with reduced ejection fraction; left ventricular ejection fraction

Year:  2018        PMID: 29892468      PMCID: PMC5971673          DOI: 10.15420/cfr.2018:7:2

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN: 2057-7540


  28 in total

Review 1.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies.

Authors:  Kavita Sharma; David A Kass
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

2.  The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%).

Authors:  Carolyn S P Lam; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2014-09-11       Impact factor: 15.534

3.  Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.

Authors:  Lars H Lund; Brian Claggett; Jiankang Liu; Carolyn S Lam; Pardeep S Jhund; Giuseppe M Rosano; Karl Swedberg; Salim Yusuf; Christopher B Granger; Marc A Pfeffer; John J V McMurray; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2018-02-12       Impact factor: 15.534

4.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher
Journal:  Eur Heart J       Date:  2012-05-19       Impact factor: 29.983

Review 5.  The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

Authors: 
Journal:  Eur Heart J       Date:  2011-08-06       Impact factor: 29.983

6.  Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.

Authors:  Richard K Cheng; Margueritte Cox; Megan L Neely; Paul A Heidenreich; Deepak L Bhatt; Zubin J Eapen; Adrian F Hernandez; Javed Butler; Clyde W Yancy; Gregg C Fonarow
Journal:  Am Heart J       Date:  2014-07-22       Impact factor: 4.749

7.  Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction.

Authors:  John R Kapoor; Roger Kapoor; Christine Ju; Paul A Heidenreich; Zubin J Eapen; Adrian F Hernandez; Javed Butler; Clyde W Yancy; Gregg C Fonarow
Journal:  JACC Heart Fail       Date:  2016-06       Impact factor: 12.035

8.  Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.

Authors:  John G F Cleland; Karina V Bunting; Marcus D Flather; Douglas G Altman; Jane Holmes; Andrew J S Coats; Luis Manzano; John J V McMurray; Frank Ruschitzka; Dirk J van Veldhuisen; Thomas G von Lueder; Michael Böhm; Bert Andersson; John Kjekshus; Milton Packer; Alan S Rigby; Giuseppe Rosano; Hans Wedel; Åke Hjalmarson; John Wikstrand; Dipak Kotecha
Journal:  Eur Heart J       Date:  2018-01-01       Impact factor: 29.983

9.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

10.  Magnitude of and Prognostic Factors Associated With 1-Year Mortality After Hospital Discharge for Acute Decompensated Heart Failure Based on Ejection Fraction Findings.

Authors:  Andrew H Coles; Mayra Tisminetzky; Jorge Yarzebski; Darleen Lessard; Joel M Gore; Chad E Darling; Robert J Goldberg
Journal:  J Am Heart Assoc       Date:  2015-12-23       Impact factor: 5.501

View more
  2 in total

1.  Snapshot evaluation of acute and chronic heart failure in real-life in Turkey: A follow-up data for mortality.

Authors:  Mehmet Birhan Yılmaz; Emrah Aksakal; Uğur Aksu; Hakan Altay; Yıldırım Nesligül; Ahmet Çelik; Mehmet Ata Akil; Lütfü Bekar; Mustafa Gökhan Vural; Rengin Çetin Güvenç; Savaş Özer; Dilek Ural; Yüksel Çavuşoğlu; Lale Tokgözoğlu
Journal:  Anatol J Cardiol       Date:  2020-02       Impact factor: 1.596

2.  Risk stratification in heart failure with mild reduced ejection fraction.

Authors:  Damiano Magrì; Giovanna Gallo; Gianfranco Parati; Mariantonietta Cicoira; Michele Senni
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.